Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 43.79
-0.52 (-1.17%)
At close: May 30, 2025, 2:57 PM CST
Bide Pharmatech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Operating Revenue | 1,136 | 1,102 | 1,092 | 833.8 | 606.05 | 391.19 | Upgrade
|
| Other Revenue | 0.01 | 0.01 | 0.03 | 0.03 | 0.17 | 0.28 | Upgrade
|
| Revenue | 1,136 | 1,102 | 1,092 | 833.83 | 606.22 | 391.46 | Upgrade
|
| Revenue Growth (YoY) | 3.05% | 0.93% | 30.95% | 37.55% | 54.86% | 57.47% | Upgrade
|
| Cost of Revenue | 684.8 | 680.35 | 673.38 | 471.29 | 315.89 | 187.32 | Upgrade
|
| Gross Profit | 450.91 | 421.66 | 418.48 | 362.54 | 290.33 | 204.14 | Upgrade
|
| Selling, General & Admin | 253.46 | 244.87 | 250.12 | 167.26 | 145.16 | 105.42 | Upgrade
|
| Research & Development | 55.35 | 55.62 | 59.72 | 43.46 | 32.1 | 18.39 | Upgrade
|
| Other Operating Expenses | 8.25 | 6.71 | 5.01 | 3.96 | 2.42 | 1.98 | Upgrade
|
| Operating Expenses | 320.96 | 308.96 | 319.18 | 218.2 | 182.75 | 128.03 | Upgrade
|
| Operating Income | 129.95 | 112.71 | 99.3 | 144.34 | 107.58 | 76.11 | Upgrade
|
| Interest Expense | -4.7 | -3.32 | -2.53 | -2.16 | -0.92 | -1.87 | Upgrade
|
| Interest & Investment Income | 18.71 | 23.74 | 31.74 | 8.86 | 3.9 | 0.76 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.99 | 4.99 | 5.93 | 12.55 | -6.67 | -7.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.22 | -4.12 | -2.5 | -2.23 | -1.08 | -1.36 | Upgrade
|
| EBT Excluding Unusual Items | 144.72 | 134 | 131.95 | 161.35 | 102.8 | 66.36 | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.12 | 3.15 | -12.63 | -0.46 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.96 | 1.15 | 0.44 | - | 7.92 | 0.09 | Upgrade
|
| Asset Writedown | -1.69 | -0.03 | -0 | -0 | -0.04 | -0.55 | Upgrade
|
| Other Unusual Items | 9.95 | 9.74 | 6.25 | 10.88 | 3.87 | 4.37 | Upgrade
|
| Pretax Income | 160.06 | 148.02 | 126 | 171.77 | 114.56 | 70.27 | Upgrade
|
| Income Tax Expense | 38.01 | 30.59 | 17.55 | 25.8 | 16.99 | 11.27 | Upgrade
|
| Earnings From Continuing Operations | 122.04 | 117.43 | 108.45 | 145.97 | 97.57 | 59 | Upgrade
|
| Minority Interest in Earnings | - | - | 1.13 | - | - | - | Upgrade
|
| Net Income | 122.04 | 117.43 | 109.57 | 145.97 | 97.57 | 59 | Upgrade
|
| Net Income to Common | 122.04 | 117.43 | 109.57 | 145.97 | 97.57 | 59 | Upgrade
|
| Net Income Growth | 23.63% | 7.17% | -24.94% | 49.60% | 65.37% | - | Upgrade
|
| Shares Outstanding (Basic) | 89 | 89 | 91 | 74 | 67 | 62 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 89 | 91 | 74 | 67 | 62 | Upgrade
|
| Shares Change (YoY) | -1.62% | -1.76% | 22.83% | 10.09% | 8.03% | 610.24% | Upgrade
|
| EPS (Basic) | 1.37 | 1.32 | 1.21 | 1.98 | 1.46 | 0.95 | Upgrade
|
| EPS (Diluted) | 1.37 | 1.32 | 1.21 | 1.98 | 1.46 | 0.95 | Upgrade
|
| EPS Growth | 25.66% | 9.09% | -38.89% | 35.89% | 53.38% | - | Upgrade
|
| Free Cash Flow | 30.28 | 69.97 | -118.47 | -8.54 | -94.09 | -34.08 | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.79 | -1.31 | -0.12 | -1.41 | -0.55 | Upgrade
|
| Dividend Per Share | 0.900 | 0.900 | 0.900 | 1.100 | - | - | Upgrade
|
| Dividend Growth | - | - | -18.18% | - | - | - | Upgrade
|
| Gross Margin | 39.70% | 38.26% | 38.33% | 43.48% | 47.89% | 52.15% | Upgrade
|
| Operating Margin | 11.44% | 10.23% | 9.09% | 17.31% | 17.75% | 19.44% | Upgrade
|
| Profit Margin | 10.75% | 10.66% | 10.04% | 17.51% | 16.10% | 15.07% | Upgrade
|
| Free Cash Flow Margin | 2.67% | 6.35% | -10.85% | -1.02% | -15.52% | -8.71% | Upgrade
|
| EBITDA | 141.16 | 123.58 | 108.85 | 150.15 | 111.51 | 78.59 | Upgrade
|
| EBITDA Margin | 12.43% | 11.21% | 9.97% | 18.01% | 18.39% | 20.08% | Upgrade
|
| D&A For EBITDA | 11.2 | 10.87 | 9.55 | 5.81 | 3.93 | 2.48 | Upgrade
|
| EBIT | 129.95 | 112.71 | 99.3 | 144.34 | 107.58 | 76.11 | Upgrade
|
| EBIT Margin | 11.44% | 10.23% | 9.09% | 17.31% | 17.75% | 19.44% | Upgrade
|
| Effective Tax Rate | 23.75% | 20.67% | 13.93% | 15.02% | 14.83% | 16.04% | Upgrade
|
| Revenue as Reported | 1,136 | 1,102 | 1,092 | 833.83 | 606.22 | - | Upgrade
|
| Advertising Expenses | - | 9.59 | 7.77 | 5.65 | 5.87 | 3.71 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.